# KemPharm Inc. (KMPH)

Source: https://www.quantisnow.com/company/KMPH
Generated: 2026-11-11T17:09:43.587Z

- Ticker: KMPH
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- Website: kempharm.com

## About

KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds that may have applications for new disease indications. Its prodrug product candidate pipeline is focused on the high need areas of attention deficit hyperactivity disorder, stimulant use disorder, and CNS rare diseases, including idiopathic hypersomnia. KemPharm's lead clinical development candidate for the treatment of stimulant use disorder, KP879, is based on its prodrug of d-methylphenidate, known as serdexmethylphnidate. In addition, the company has received FDA approval for AZSTARYS, a new once-daily treatment for attention deficit hyperactivity disorder in patents age six years and older, and for APADAZ, an immediate-release combination product containing benzhydrocodone, a prodrug of hydrocodone, and acetaminophen. KemPharm, Inc. has collaboration and license agreement, with KVK-Tech, Inc. The company was incorporated in 2006 and is headquartered in Celebration, Florida.

## Latest KMPH news and filings

- 2024-02-14 21:51 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by KemPharm Inc.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-kempharm-inc-5264510)
- 2024-02-03 02:39 UTC [SEC Form S-3] [SEC Form S-3 filed by KemPharm Inc.](https://www.quantisnow.com/insight/sec-form-s-3-filed-by-kempharm-inc-5228110)
- 2024-02-03 02:22 UTC [SEC Form 4] [SEC Form 4 filed by Schafer Joshua](https://www.quantisnow.com/insight/sec-form-4-filed-by-schafer-joshua-5227916)
- 2024-02-03 01:17 UTC [SEC Form 4] [SEC Form 4 filed by Sangiovanni Timothy J.](https://www.quantisnow.com/insight/sec-form-4-filed-by-sangiovanni-timothy-j-5227849)
- 2024-02-03 01:14 UTC [SEC Form 4] [SEC Form 4 filed by Mickle Christal M M](https://www.quantisnow.com/insight/sec-form-4-filed-by-mickle-christal-m-m-5227846)
- 2024-02-03 01:13 UTC [SEC Form 4] [SEC Form 4 filed by Guenther Sven](https://www.quantisnow.com/insight/sec-form-4-filed-by-guenther-sven-5227842)
- 2024-02-03 01:11 UTC [SEC Form 4] [SEC Form 4 filed by Clifton R. Laduane](https://www.quantisnow.com/insight/sec-form-4-filed-by-clifton-r-laduane-5227839)
- 2024-02-03 01:10 UTC [SEC Form 4] [SEC Form 4 filed by Mcfarlane Neil F.](https://www.quantisnow.com/insight/sec-form-4-filed-by-mcfarlane-neil-f-5227837)
- 2024-02-03 01:08 UTC [SEC Form 4] [SEC Form 4 filed by Shih Alvin](https://www.quantisnow.com/insight/sec-form-4-filed-by-shih-alvin-5227832)
- 2024-02-02 12:13 UTC [SEC Form 3] [SEC Form 3 filed by new insider Shih Alvin](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-shih-alvin-5225064)
- 2024-01-29 22:25 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by KemPharm Inc.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-kempharm-inc-5214809)
- 2024-01-23 12:37 UTC [SEC Form 8-K] [KemPharm Inc. filed SEC Form 8-K: Leadership Update](https://www.quantisnow.com/insight/kempharm-inc-filed-sec-form-8-k-leadership-update-5200182)
- 2024-01-08 13:03 UTC [SEC Form 8-K] [KemPharm Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/kempharm-inc-filed-sec-form-8-k-regulation-fd-disclosure-other-5175003)
- 2023-12-27 12:48 UTC [SEC Form 8-K] [KemPharm Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/kempharm-inc-filed-sec-form-8-k-regulation-fd-disclosure-financial-5155572)
- 2023-11-22 00:40 UTC [SEC Form 424B5] [SEC Form 424B5 filed by KemPharm Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-kempharm-inc-5099898)
- 2023-11-20 12:36 UTC [SEC Form 8-K] [KemPharm Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/kempharm-inc-filed-sec-form-8-k-entry-into-a-material-5094751)
- 2023-11-07 22:23 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by KemPharm Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-kempharm-inc-5067342)
- 2023-11-07 12:25 UTC [SEC Form 8-K] [KemPharm Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/kempharm-inc-filed-sec-form-8-k-results-of-operations-and-5064037)
- 2023-10-30 20:42 UTC [SEC Form 425] [SEC Form 425 filed by KemPharm Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-kempharm-inc-5044628)
- 2023-10-30 12:25 UTC [SEC Form 8-K] [KemPharm Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/kempharm-inc-filed-sec-form-8-k-other-events-financial-statements-5043013)
- 2023-10-11 20:33 UTC [SEC Form 4] [SEC Form 4 filed by Mcfarlane Neil F.](https://www.quantisnow.com/insight/sec-form-4-filed-by-mcfarlane-neil-f-5015654)
- 2023-10-11 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by KemPharm Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-kempharm-inc-5013976)
- 2023-10-11 00:20 UTC [SEC Form 3] [SEC Form 3 filed by new insider Mcfarlane Neil F.](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-mcfarlane-neil-f-5013778)
- 2023-10-10 21:12 UTC [SEC Form 8-K] [KemPharm Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/kempharm-inc-filed-sec-form-8-k-leadership-update-financial-statements-5013539)
- 2023-10-10 21:07 UTC [SEC Form 424B3] [SEC Form 424B3 filed by KemPharm Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-kempharm-inc-5013525)
- 2023-10-06 20:06 UTC [SEC Form S-4] [SEC Form S-4/A filed by KemPharm Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-s-4a-filed-by-kempharm-inc-amendment-5009364)
- 2023-09-29 01:25 UTC [SEC Form S-4] [SEC Form S-4 filed by KemPharm Inc.](https://www.quantisnow.com/insight/sec-form-s-4-filed-by-kempharm-inc-4993735)
- 2023-09-06 21:11 UTC [SEC Form 4] [SEC Form 4: Schafer Joshua bought $2,564 worth of shares (500 units at $5.13), increasing direct ownership by 17% to 3,500 units](https://www.quantisnow.com/insight/sec-form-4-schafer-joshua-bought-2564-worth-of-shares-4957110)
- 2023-09-06 21:11 UTC [SEC Form 4] [SEC Form 4: Clifton R. Laduane bought $4,959 worth of shares (1,000 units at $4.96), increasing direct ownership by 7% to 15,309 units](https://www.quantisnow.com/insight/sec-form-4-clifton-r-laduane-bought-4959-worth-of-4957106)
- 2023-09-06 20:40 UTC [SEC Form 4] [SEC Form 4: Bode John B bought $51,333 worth of shares (10,000 units at $5.13), increasing direct ownership by 100% to 20,000 units](https://www.quantisnow.com/insight/sec-form-4-bode-john-b-bought-51333-worth-of-4956855)
- 2023-09-06 20:39 UTC [SEC Form 4] [SEC Form 4: Anderson Thomas bought $48,764 worth of shares (10,000 units at $4.88)](https://www.quantisnow.com/insight/sec-form-4-anderson-thomas-bought-48764-worth-of-shares-4956842)
- 2023-08-31 21:25 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by KemPharm Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-kempharm-inc-4948460)
- 2023-08-31 21:25 UTC [SEC Form 8-K] [KemPharm Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/kempharm-inc-filed-sec-form-8-k-other-events-financial-statements-4948450)
- 2023-08-31 12:03 UTC [SEC Form 425] [SEC Form 425 filed by KemPharm Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-kempharm-inc-4946862)
- 2023-08-31 12:01 UTC [SEC Form 8-K] [KemPharm Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/kempharm-inc-filed-sec-form-8-k-entry-into-a-material-4946851)
- 2023-08-25 20:19 UTC [SEC Form 4] [SEC Form 4 filed by Anderson Thomas](https://www.quantisnow.com/insight/sec-form-4-filed-by-anderson-thomas-4939053)
- 2023-08-24 21:07 UTC [SEC Form 3] [SEC Form 3 filed by new insider Anderson Thomas](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-anderson-thomas-4937326)
- 2023-08-14 20:34 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by KemPharm Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-kempharm-inc-4895288)
- 2023-08-14 11:48 UTC [SEC Form 8-K] [KemPharm Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/kempharm-inc-filed-sec-form-8-k-results-of-operations-and-4888485)
- 2023-08-07 20:52 UTC [SEC Form 8-K] [KemPharm Inc. filed SEC Form 8-K: Leadership Update](https://www.quantisnow.com/insight/kempharm-inc-filed-sec-form-8-k-leadership-update-4856977)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/KMPH
- Earnings history: https://www.quantisnow.com/earnings/KMPH
- Dividend history: https://www.quantisnow.com/dividends/KMPH
- Insider transactions: https://www.quantisnow.com/insiders/KMPH
- Options chain: https://www.quantisnow.com/options/KMPH
- SEC 8-K filings only: https://www.quantisnow.com/company/KMPH/8-k
- RSS and alerts for KMPH: https://www.quantisnow.com/docs/rss-feeds.md